Advanced Prostate Cancer Series: Metastatic Hormone-Sensitive Disease

Metastatic prostate cancer means that the cancer has spread outside the prostate region to other parts of the body. In Part One in a series on advanced and metastatic prostate cancer, this month we focus on “hormone sensitive” disease: the earlier stages, in which patients started on hormone therapy see their PSA drop as the tumor shrinks. PCF Chief Medical Officer Dr. William K. Oh speaks with two highly experienced clinicians in urology and medical oncology. Learn how metastatic hormone-sensitive prostate cancer develops, what your treatment options are, possible side effects, and questions to ask your doctor.

This webinar is generously supported by Lantheus.

View Advanced Prostate Cancer Series: Metastatic Hormone-Sensitive Disease transcript.